CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth. - Lin, Yihua; Zhao, Yiling; Chen, Minggui; Li, Zishuo; Liu, Qiao; Chen, Jian; Ding, Yi; Ding, Chunyong; Ding, Ye; Qi, Cuiling; Zheng, Lingyun; Li, Jiangchao; et al. (BMC Cancer, 2023)